The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MASS-FIX versus standard methods to predict for PFS and OS among multiple myeloma patients participating on the STAMINA trial.
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - BMS
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Pfizer; Regeneron
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Bonnie Arendt
No Relationships to Disclose
 
Surendra Dasari
No Relationships to Disclose
 
Yvonne Adeduni Efebera
Honoraria - Takeda
Speakers' Bureau - Akcea Therapeutics; Janssen; Takeda
 
Nancy Geller
Stock and Other Ownership Interests - Danaher
 
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Theresa Hahn
No Relationships to Disclose
 
Mindy C. Kohlhagen
No Relationships to Disclose
 
Heather Jolie Landau
Consulting or Advisory Role - Caelum Biosciences; Celgene; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Takeda
Research Funding - Takeda
 
Parameswaran Hari
Honoraria - Abbvie/Pharmacyclics; Amgen; BMS; GlaxoSmithKline; Incyte; Janssen Oncology; Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics; Sanofi; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Marcelo C. Pasquini
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Medigene (Inst); Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Kite/Gilead (Inst); Novartis (Inst)
 
Muzaffar H. Qazilbash
Speakers' Bureau - Merck; Sanofi
Research Funding - Amgen; Angiocrine Bioscience; BiolineRx; Janssen
 
Philip L. McCarthy
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; The Binding Site
Consulting or Advisory Role - Bluebird Bio; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Magenta Therapeutics; Sanofi; The Binding Site
Research Funding - Celgene (Inst)
 
Nina Shah
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Oncopeptides; Precision Biosciences; Sanofi; Surface Oncology
Research Funding - Bluebird Bio; Celgene; Janssen; Nektar; poseida therapeutics; Sutro biopharma; Teneobio
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis; Sorrento Therapeutics
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Sanofi; Takeda
 
Dan T. Vogl
Consulting or Advisory Role - Active Biotech; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Active Biotech
Travel, Accommodations, Expenses - Amgen; Karyopharm Therapeutics; Takeda
 
Paul K. Wallace
No Relationships to Disclose
 
Edward A. Stadtmauer
Consulting or Advisory Role - Amgen (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst)
 
David L. Murray
Consulting or Advisory Role - The Binding Site (Inst)
Research Funding - The Binding Site (Inst)
Patents, Royalties, Other Intellectual Property - miRAMM